No abstract available
MeSH terms
-
Antineoplastic Agents / therapeutic use*
-
Biomarkers, Tumor / analysis
-
Clinical Trials, Phase I as Topic / methods
-
Clinical Trials, Phase II as Topic / methods
-
Clinical Trials, Phase III as Topic / methods
-
Drug Therapy, Combination
-
Humans
-
Multiple Myeloma / drug therapy*
-
Patient Selection
-
Randomized Controlled Trials as Topic / methods
-
Treatment Outcome
Substances
-
Antineoplastic Agents
-
Biomarkers, Tumor